4//SEC Filing
MEDICINES CO /DE 4
Accession 0001179110-17-003721
CIK 0001113481operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:08 PM ET
Size
10.2 KB
Accession
0001179110-17-003721
Insider Transaction Report
Form 4
MEDICINES CO /DEMDCO
Frazier Jeff
EVP, Chief Human Strategy Ofcr
Transactions
- Award
Common Stock
2017-03-01+5,693→ 38,422 total - Tax Payment
Common Stock
2017-03-02$52.40/sh−1,045$54,758→ 37,377 total - Award
Common Stock
2017-02-28$33.12/sh+320$10,598→ 32,729 total - Award
Stock Option (right-to-buy)
2017-03-01+35,133→ 35,133 totalExercise: $52.70Exp: 2027-03-01→ Common Stock (35,133 underlying)
Footnotes (4)
- [F1]Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning September 1, 2016 and ending February 28, 2017. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on September 1, 2016.
- [F2]Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
- [F3]Shares of common stock were withheld for payment of taxes in connection with the vesting of 3,054 shares of restricted stock from previously reported grants.
- [F4]The option vests in forty-eight equal installments beginning April 1, 2017.
Documents
Issuer
MEDICINES CO /DE
CIK 0001113481
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001113481
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:08 PM ET
- Size
- 10.2 KB